Schrödinger, WuXi AppTec launch drug discovery JV

Computational physics company Schrödinger LLC (New York, N.Y.) and Shanghai-based R&D company WuXi AppTec Co. Ltd. (Shanghai:603259) created drug discovery JV Faxian Therapeutics (New York, N.Y.).

The JV will use Schrödinger's precision molecular design platforms to identify targets and indications with WuXi AppTec's small molecule design-synthesize-test cycle. Terms are not disclosed. Schrödinger declined to disclose ownership stakes and funding for Faxian...